Youngs Advisory Group, Inc. Astrazeneca PLC Transaction History
Youngs Advisory Group, Inc.
- $236 Million
- Q4 2024
A detailed history of Youngs Advisory Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Youngs Advisory Group, Inc. holds 3,350 shares of AZN stock, worth $241,501. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,350
Previous 3,169
5.71%
Holding current value
$241,501
Previous $246,000
10.98%
% of portfolio
0.09%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,393Shares Held
473MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.35 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.96 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.7 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.73 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.4 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...